ArticleJournal of atherosclerosis and thrombosis2017
A First-in-Class Drug, Lomitapide, Tailored to Patients with Homozygous Familial Hypercholesterolemia is Just about Meeting with Good News to Them.
Hiroshi YoshidaPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.